GSK plc
GSK
#185
Rank
A$167.14 B
Marketcap
A$83.29
Share price
-0.24%
Change (1 day)
45.59%
Change (1 year)

Market capitalization of GSK plc (GSK)

Market cap: A$167.14 Billion

As of February 2026 GSK plc has a market cap of A$167.14 Billion. This makes GSK plc the world's 185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GSK plc from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$167.14 B12.71%
2025A$148.29 B32.66%
2024A$111.78 B-0.12%
2023A$111.92 B5.88%
2022A$105.70 B-29.76%
2021A$150.49 B26.11%
2020A$119.34 B-28.21%
2019A$166.23 B24.66%
2018A$133.34 B18.14%
2017A$112.87 B-13.65%
2016A$130.71 B-3.87%
2015A$135.97 B6.83%
2014A$127.28 B-12%
2013A$144.63 B42.11%
2012A$101.77 B-9.41%
2011A$112.34 B11.99%
2010A$100.31 B-17.82%
2009A$122.07 B-10.9%
2008A$137.00 B-13.69%
2007A$158.74 B-17.59%
2006A$192.61 B-4.36%
2005A$201.40 B10.78%
2004A$181.80 B2.62%
2003A$177.16 B-11.54%
2002A$200.27 B-33.53%
2001A$301.30 B-4.37%
2000A$315.07 B103.55%
1999A$154.78 B-24.78%
1998A$205.77 B56.66%
1997A$131.34 B85.38%
1996A$70.85 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of GSK plc was reported to be:

A$169.88 Billion
by Nasdaq info icon info icon
A$167.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$455.12 B 172.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$217.40 B 30.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$160.97 B-3.69%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$436.12 B 160.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$451.27 B 170.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$55.65 B-66.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A$2.56 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA